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Abstract
The type III secretion system (T3SS) is a complex nanomachine of many pathogenic Gram-negative bacteria. It forms
a proteinaceous channel that is inserted into the host eukaryotic cell membrane for injection of bacterial proteins that
manipulate host cell signaling. However, few studies have focused on the effector-independent functions of the T3SS. Using
a murine model of acute lung infection with Pseudomonas aeruginosa, an important human opportunistic pathogen, we
compared the pathogenicity of mutant bacteria that lack all of the known effector toxins ( DSTY), with mutant bacteria that
also lack the major translocator protein PopB (DSTY/DPopB) and so cannot form a functional T3SS channel in the host cell
membrane. Mortality was higher among mice challenged with DSTY compared to mice challenged with DSTY/DPopB
mutant bacteria. In addition, mice infected with DSTY showed decreased bacterial clearance from the lungs compared to
those infected with DSTY/DPopB. Infection was in both cases associated with substantial killing of lung infiltrating
macrophages. However, macrophages from DSTY-infected mice died by pro-inflammatory necrosis characterized by
membrane permeabilization and caspase-1 mediated IL-1b production, whereas macrophages from DSTY/DPopB infected
mice died by apoptosis, which is characterized by annexin V positive staining of the cell membrane and caspase-3
activation. This was confirmed in macrophages infected in vitro. These results demonstrate a T3SS effector toxin
independent role for the T3SS, in particular the T3SS translocator protein PopB, in the pathogenicity of P. aeruginosa during
acute lung infection.
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Introduction
Pseudomonas aeruginosa is a Gram-negative bacterium found
ubiquitously in soil and water habitats. It is an opportunistic
pathogen that causes serious, often antibiotic resistant, infections
in immunocompromised individuals, burn victims and patients
requiring mechanical ventilation [1,2]. For example, once
P. aeruginosa is established in the airways of cystic fibrosis patients,
it is almost impossible to eradicate, and the result is frequently
mortality [3]. Most clinical isolates of P. aeruginosa secrete virulence
determinants and also possess a specialized proteinaceous appa-
ratus associated with the cell wall which is used to translocate
toxins into eukaryotic cells. This is known as the type III secretion
system (T3SS). The T3SS is a potent virulence mechanism shared
by Pseudomonas and many other pathogenic Gram-negative
bacteria that inject T3SS effector proteins into the cytosol of
their host cells [4,5]. The T3SS is a complex syringe-like apparatus
on the bacterial surface and consists of five groups of proteins: the
needle complex, the translocation apparatus, regulator proteins,
chaperones and effector toxins. The needle complex is responsible
for the transport of effector toxins from the bacterial cytosol to the
outside. The translocation apparatus is a membrane pore that
accepts the effector proteins secreted by the needle complex and
delivers them across the host cell plasma membrane. The T3SS of
P. aeruginosa uses three proteins for translocation: PopB, PopD and
PcrV [6]. The latter is located at the distal end of the needle and
serves as a molecular platform where PopB and PopD form the
translocation pore by oligomerisation. The exact regulation of the
polymerization is poorly understood. PopB, PopD and PcrV are
secreted via the T3SS and are absolutely required for pore
formation and translocation of effectors across the host cell plasma
membrane [7,8]. In Yersinia YopB, it was demonstrated that
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secreted translocators cannot cross-complement a yopB null
mutant, which suggests that pore formation requires that the
secreted translocators remain in close proximity to the needle [9].
The steps of triggering effector secretion upon cell contact have
not been elucidated, but several events are known to occur. First,
the bacterium makes contact with the cell, a process mediated by
specific adhesins [9]. Then, the T3SS is brought close to the
plasma membrane and the translocator proteins PopB and PopD
are inserted into the host membrane to form the translocation pore
[10,11]. The needle tip protein PcrV is required for appropriate
assembly and insertion of PopB and PopD into host membranes
[8,12]. After formation of the translocation pore and docking of
the needle to the pore, effector secretion is triggered. Transcription
and secretion of the T3SS effector proteins are regulated by
specific regulator proteins. In vitro, secretion can be triggered by
calcium depletion or by contact with host cells [13]. Proteins
destined for secretion by T3SS are bound by chaperones that
facilitate their storage in the cytosol and delivery to the secretion
apparatus. P. aeruginosa has four known effector toxins: ExoS,
ExoT, ExoY and ExoU. These proteins can modify signal
transduction pathways and counteract innate immunity [14].
ExoS and ExoT are bifunctional enzymes with GTPase activating
protein (GAP) activity and ADP ribosyl transferase (ADPRT)
activity, which target several proteins, including Ras and Ras-like
GTPases. These two distinct enzymatic activities work redundant-
ly to disrupt the actin cytoskeleton, resulting in profound effects on
host cellular processes [15]. While the ADPRT domains of ExoS
and ExoT are highly homologous and both require the 14-3-3
family protein FAS as a cofactor, their targets are very different. In
contrast to ExoS, which has poly-substrate specificity, ExoT ADP-
ribosylates a more restricted subset of host proteins, including the
Crk adaptor proteins. Expression of the ADPRT domain of ExoS
is toxic to cultured cells, while expression of ExoT appears to
interfere with host cell phagocytic activity [15]. We previously
reported that ExoS negatively regulates the P. aeruginosa induced
interleukin-1b (IL-1b) maturation and secretion by a mechanism
that is dependent on its ADPRT activity [16]. ExoY is an
adenylate cyclase that requires an unidentified host cell cofactor
for it activity. Its role in virulence remains uncertain, though it can
cause cell rounding upon cocultivation with cells [17] and is toxic
when expressed in yeast [18]. ExoU has been characterized as
a member of the phospholipase family of enzymes and has at least
phospholipase A2 activity [19]. Similar to ExoS, ExoT and ExoY,
ExoU requires either a eukaryote-specific cofactor for its activity
and ubiquitinated proteins, as well as ubiquitin itself, have been
suggested as being potential activators of the toxin [20]. In
mammalian cells, the direct injection of ExoU causes irreversible
damage to cellular membranes and rapid necrotic death. ExoS
and ExoU are rarely found together in one strain. Both genotypes
(ExoS/ExoT and ExoU/ExoT) are associated with acute infections
in humans, though ExoU-producing strains are under-represented
in persistently infected cystic fibrosis patients [21].
While much of the T3SS mediated damage is probably caused
by the translocated effectors, there is increasing evidence that
insertion of the needle complex itself can contribute to virulence.
For example, the Yersinia T3SS translocator proteins YopB and
YopD can form pores that allow ion influx [22] and trigger the
maturation and release of pro-inflammatory IL-1b [23]. Bacterial
flagellin and the inner rod component of the T3SS apparatus from
several bacterial species (e.g. PrgJ from S. typhimurium or PscI from
P. aeruginosa) can be detected in the host cell cytoplasm by members
of a small subfamily of NLR (nucleotide-binding domain leucine-
rich repeat containing) proteins, the NAIPs (NLR family, apoptosis
inhibitory proteins) [24,25]. Once activated, NAIPs appear to be
critical for inducing assembly of the NLRC4 (formerly called
IPAF) inflammasome, a large cytoplasmic complex that induces
caspase-1 activation dependent proIL-1b maturation and pyr-
optotic cell death [26]. It should be mentioned that these studies
were obtained with mouse cells, which express multiple NAIP
paralogues. However, humans express only one NAIP and this
protein was shown to recognize neither flagellin nor the inner rod
(PrgJ-like) proteins of T3SS. Instead, it appears that human NAIP
can detect the needle subunit of several different T3SSs, including
PscF from P. aeruginosa and PrgI from S. typhimurium [24]. The
current model is that different components of the T3SS are
directly recognized by NAIPs but a major caveat is that evidence is
mainly based on overexpression of the corresponding proteins in
heterologous cell types.
Consistent with a role for the P. aeruginosa T3SS in caspase-1
activation, we previously showed that DS/DPopB P. aeruginosa
(mutated in the effector protein ExoS and the translocator protein
PopB), in contrast to DS bacteria (mutated only in ExoS), cannot
activate proIL-1b maturation in a macrophage cell line [16].
However, as absence of PopB prevents the formation of
a functional translocation channel as well as injection in the host
cytoplasm of T3SS effector proteins other than ExoS, the exact
contribution of the T3SS in the activation of caspase-1 and proIL-
1b maturation is in this case unclear. Also, so far the role of the
T3SS translocation pore in P. aeruginosa lung infection has not been
studied in vivo. Using a murine model of acute lung infection as
well as in vitro infection of macrophages, and comparing a mutant
P. aeruginosa PAK strain that lacks any of the known effector toxins
(DSTY), with mutant bacteria that also lack the major translocator
protein PopB ( DSTY/DPopB), we provide evidence that T3SS
plays a role in the pathogenicity of P. aeruginosa that is independent
of the known effector toxins.
Results
The T3SS Translocation Pore Contributes to Mortality in
Acute Lung Infection Independently of the Injection of
T3SS Effector Proteins ExoS, -T, and -Y
To investigate the toxin-independent function of the T3SS in
the pathogenicity of P. aeruginosa, we compared the survival rates of
8-week-old C57BL/6 mice after intratracheal infection with
8.16107 cfu of a P. aeruginosa mutant PAK strain that lacks all
known T3SS effector proteins but can still form a T3SS trans-
location pore (DSTY) and mice infected with a mutant strain that
also lacks the major T3SS translocator protein PopB (DSTY/
DPopB) and so cannot form a functional translocation channel.
Non-infected (NI) mice instilled with PBS and mice infected with
wild type (WT) bacteria were used as controls. Mortality was
recorded for 24 h, after which no further deaths occurred. All NI
mice survived and recovered fully from PBS instillation after 1 h.
All mice challenged with WT or DSTY bacteria died within 16 h
of challenge. DSTY bacteria do not produce the effector toxins
ExoS, ExoT and ExoY expressed by WT bacteria, and so these
T3SS effector proteins probably do not play a role in death from
acute lung infection with P. aeruginosa. In contrast, the DSTY/
DPopB mutant, which cannot form a functional T3SS trans-
location pore, resulted in significantly less mortality than the WT
and DSTY strains (p = 0.0001 and p= 0.0004, respectively;
Figure 1). A DPopB mutant behaved completely similar as the
DSTY/DPopB mutant (data not shown), which is consistent with
its inability to inject the T3SS effector proteins due to the lack of
a functional T3SS translocation pore. These results show an
important role for PopB in P. aeruginosa pathogenicity that is
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independent from its function in the secretion of ExoS, ExoT and
ExoY.
The T3SS Translocation Pore Prevents Bacterial Clearance
from the Lungs Independently from the Injection of T3SS
Effector Proteins ExoS, -T, and -Y
To further investigate the toxin-independent role of PopB in the
virulence of P. aeruginosa in vivo, we compared the bacterial load in
lungs of C57BL/6 mice challenged intratracheally with
1.16106 cfu of the P. aeruginosa DSTY or DSTY/DPopB strain
at different times post infection. For up to 1 h after infection, the
bacterial load was similarly high for both mutant strains, but later
on the number of bacteria in the lungs was significantly lower in
mice infected with DSTY/DPopB than in mice infected with
DSTY (Figure 2). Bacterial titers in the blood were low at the time
points measured, and no significant differences could be seen
between mice infected with DSTY/DPopB or with DSTY (data
not shown). The lower bacterial load in the lungs of mice infected
with DSTY/DPopB compared to DSTY indicates that a functional
T3SS translocation channel can prevent bacterial clearance even
in the absence of any of the known T3SS effector proteins.
The T3SS Translocation Pore Determines the Type of
Pulmonary Macrophage Cell Death Independently of the
Injection of T3SS Effector Proteins ExoS, -T, and -Y
To further investigate the observed difference in pathogenicity
between DSTY/DPopB and DSTY in acute lung infection, we
counted inflammatory cells in the BALF of C57BL/6 mice that
were challenged intratracheally with 1.16106 cfu of a P. aeruginosa
WT, DSTY or DSTY/DPopB strain, and after 4.5 h, neutrophils
(Gr1+/CD11c2) and macrophages/dendritic cells (CD11c+) in
BALF were counted by flow cytometry. As expected, P. aeruginosa
infection resulted in the infiltration mainly of neutrophils.
However, there were no differences between DSTY/DPopB or
DSTY infected mice (Figure 3A). We next evaluated the viability
of the inflammatory cells by labeling them with Sytox Red and
Annexin-V-FITC. The Sytox Red dye only stains necrotic cells
[27], whereas Annexine-V positivity indicates apoptosis [28].
P. aeruginosa infection resulted in significant cell death of residual
macrophages and infiltrated neutrophils (Figure 3B). Overall death
of macrophages and neutrophils (Annexin-V positive plus Sytox
Red positive) was not significantly different between mice infected
with WT, DSTY/DPopB or DSTY bacteria. However, the Sytox
Red positive macrophage population was larger in DSTY infected
mice than in mice infected with WT or DSTY/DPopB bacteria
(p,0.01), which indicates that DSTY infection preferentially
triggers a necrotic cell death in macrophages (Figure 3C, left
panel). In contrast, the Annexin-V signal positive macrophage
population was significantly larger in DSTY/DPopB infected mice
than in mice infected with WT or DSTY bacteria (p,0.05), which
indicates that DSTY/DPopB infection preferentially triggers
apoptosis in macrophages (Figure 3C, right panel). There were
no significant differences in the neutrophil mode of cell death after
infection with WT or mutant P. aeruginosa strains (data not shown).
All together, these data indicate that macrophage cell death can be
induced by P. aeruginosa that lack a functional T3SS translocation
channel, but implicate a role for the latter, independent of ExoS, -
T and -Y, in directing cell death from apoptosis towards necrosis.
The T3SS Translocation Pore Initiates the Maturation and
Secretion of IL-1b Independent from the Injection of
T3SS Effector Proteins ExoS, -T, and -Y
We previously showed that the T3SS effector protein ExoS
inhibits the caspase-1 mediated proteolytic maturation and
secretion of IL-1b in response to P. aeruginosa infection [16].
Moreover, we showed that infection of a macrophage cell line with
a P. aeruginosa a DPopB or DS/DPopB mutant failed to induce IL-
1b maturation, which points to a role for PopB in this process. To
determine whether PopB could trigger IL-1b maturation in vivo
independently of any of the other known T3SS effector proteins,
we intratracheally infected C57BL/6 mice with 1.16106 cfu of
WT, DSTY or DSTY/DPopB P. aeruginosa and determined the
presence of proIL-1b in total lung extracts and mature IL-1b in
BALF 4.5 h post infection. Infection with all strains led to up-
regulation of proIL-1b (Figure 4). However, mature IL-1b was
only produced in response to infection with DSTY bacteria, which
is consistent with our previous finding that ExoS interferes with
caspase-1 mediated maturation of IL-1b [16]. Additional deletion
of PopB, however, made DSTY bacteria unable to induce IL-1b
maturation. These data indicate that the formation of a functional
T3SS translocation channel triggers the activation of IL-1b
maturation, independently from any of the known T3SS effector
proteins.
The T3SS Translocation Pore Affects Cell Death and IL-1b
Maturation of Cultured Macrophages, Independent of
the Injection of T3SS Effector Proteins ExoS, -T, and –Y
To further explore whether the above described effect of PopB
in the murine model of P. aeruginosa lung infection reflects a direct
effect on macrophages, we compared the same DSTY/DPopB and
DSTY mutant strains for their ability to cause macrophage death
and IL-1b maturation in vitro. The macrophage MF4/4 cell line
was infected with P. aeruginosa at a multiplicity of infection (MOI)
of 100. Necrosis-like cell death, associated with membrane
permeabilization, was measured by LDH release in the medium.
Apoptosis, associated with caspase-3 activation, was measured by
determining caspase-3 activity in total cell lysates using the
fluorescent peptide substrate Ac-DEVD-AMC. Cell death was
followed for 6 h after infection, at which time about half of the
DSTY infected cells were floating in the medium. WT and DSTY
infected cells showed substantial LDH release, which was more
pronounced in the case of DSTY infection (Figure 5A). However,
DSTY/DPopB infected cells did not show any LDH release. In
contrast, there was biphasic activation of caspase-3 in WT and
DSTY/DPopB infections, but not in DSTY infection (Figure 5B).
Figure 1. Survival of mice infected with different P. aeruginosa
T3SS mutant bacteria. A lethal dose of 8.17 cfu of WT P. aeruginosa
or DSTY or DSTY/DPopB mutant strains was instillated intratracheally in
C57BL/6 mice. (n = 10 for each group, NI = non-infected). Mortality was
monitored for 24 h. Results are representative of three independent
experiments. ***P#0.001.
doi:10.1371/journal.pone.0041547.g001
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Finally, we also tested the proteolytic maturation of proIL-1b in
these cells. Because the strong cytotoxic effect prevented the
induction of proIL-1b, we pretreated the cells with 100 ng/ml
LPS for 4 h, which induced the expression of proIL-1b but not its
maturation. WT bacteria induced only marginal maturation of IL-
1b, which was significantly higher in DSTY infected cells. In
contrast, additional deletion of PopB (DSTY/DPopB) inhibited the
ability from the pathogen to induce IL-1b maturation (Figure 5C).
All together, these in vitro results are consistent with the results
obtained in the in vivo lung infection model, which indicates that
the T3SS translocation channel has a direct function that is
independent of the known T3SS effector proteins in P. aeruginosa
infected macrophages.
Discussion
Much effort has been put in the functional and structural
characterization of the T3SS of P. aeruginosa and other Gram-
negative bacteria, and its interaction with the host cell. These
studies have focused mainly on the role of the T3SS effector
proteins (ExoS, ExoT, ExoY, ExoU in the case of P. aeruginosa) in
virulence. While this manuscript was under revision, T3SS rod
and needle proteins were shown to trigger the activation of the
NAIP/NLRC4 inflammasome when expressed in mammalian
cells [24–26], illustrating functions of the T3SS beyond the
injection of T3SS effector proteins. In the present study, we
compared the pathogenicity of P. aeruginosa WT bacteria (PAK
strain, which is deficient for ExoU) with that of mutant bacteria
DSTY (devoid of ExoS, ExoT and ExoY) and DSTY/DPopB
(devoid of ExoS, ExoT, ExoY, and the T3SS translocator protein
PopB). The DSTY/DPopB mutant has an intact needle complex
but cannot form pores in host cells or translocate T3SS effector
proteins. Using a murine model of acute lung infection as well as
infection of cultured macrophages with the above described
mutants, we provide evidence that the T3SS translocation pore
plays an important role in P. aeruginosa pathogenicity that is
independent of the injection of any of the known T3SS effector
proteins. This is illustrated by the findings that compared to
DSTY/DPopB, infection with DSTY leads to higher mortality,
reduced bacterial clearance, and non-apoptotic killing of alveolar
macrophages, which is associated with the production of pro-
inflammatory IL-1b. Absence of IL-1b production in DSTY/
DPopB infected mice might contribute to the more efficient
clearance of the bacteria from the lungs and the lower mortality
compared to DSTY infected mice. This is consistent with previous
data showing that absence or reduction of endogenous IL-1b
activity improves host defense against Pseudomonas pneumonia
while suppressing the inflammatory response [29]. The extended
life of DSTY/DPopB infected mice compared to DSTY infected
mice may therefore not only reflect a reduction in the bacterial
burden but also the observed reduction in the amount of IL-1b,
which is known to trigger several signaling cascades leading to
massive inflammation and multiple organ failure. In this context, it
was previously shown that several cytokines, among them IL-1b,
were present at significantly higher levels in BALF from mice
infected with bacteria possessing an intact T3SS than in mice
infected with a PcrV mutant that is unable to form a translocation
pore [30]. We previously showed that ExoS interferes with the
P. aeruginosa induced activation of caspase-1 and the production of
IL-1b in a macrophage cell line [16]. However, we did not observe
a significant difference in survival between WT-infected and
DSTY-infected mice in the current study. It is likely that the
relative importance of ExoS in immune evasion depends on
specific factors such as bacterial load and site of infection, or differs
in acute versus chronic infection. The specific role of ExoS in
immune evasion awaits further studies directly comparing in-
fection under different conditions.
Consistent with the lower mortality seen in mice infected with
DSTY/DPopB compared to those infected with DSTY, the
DSTY/DPopB bacteria were more efficiently cleared from the
lungs. Bacterial clearance is mediated mainly by neutrophils and
macrophages. P. aeruginosa lung infection has been shown to induce
the recruitment of neutrophils [31], which we confirmed in our
study. Abolishing neutrophil recruitment, due to the T3SS,
decreases bacterial clearance [30,32]. However, we did not find
a significant difference in the number of alveolar neutrophils
between mouse infections with WT, DSTY or DSTY/DPopB. It
Figure 2. Bacterial load in the lungs of mice infected with different P. aeruginosa T3SS mutants. C57BL/6 mice were infected
intratracheally with 1.16 cfu of P. aeruginosa of the DSTY or DSTY/DPopB mutant strain. Bacterial load was determined by counting at different time
points post infection (PI) the number of viable bacteria in lung homogenates. Lung homogenates were diluted serially with sterile water and placed
on LB agar plates for 24 h at 37uC (n = 6 mice per group; NI = non-infected). Bars show means and standard deviations (SD) and are representative of
3 independent experiments. **0.001#P#0.01; ***P#0.001; ns = not significant.
doi:10.1371/journal.pone.0041547.g002
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should be noted that the previously observed T3SS-induced
decrease in neutrophils occurred 12 h after infection, which is
much later than the time (4 hours) at which we observed
a difference in bacterial clearance. Several studies reported an
important function of alveolar macrophages in P. aeruginosa
induced pneumonia [31,33,34]. Here, we show that the number
of residual alveolar macrophages is significantly decreased in
P. aeruginosa infected mice, consistent with increased macrophage
cell death. A contribution of the T3SS to the killing of
macrophages has been described in animal models of P. aeruginosa
acute lung infections [35] and in clinical studies of lower
respiratory tract infections and ventilator-acquired pneumonia
[36,37]. However, these studies attributed the role of the T3SS to
the activity of T3SS effector proteins that are injected in the host
cell cytosol, and did not study a potential T3SS effector
independent function of the T3SS. Our data show that the
formation of the T3SS translocation pore itself, rather than the
injection of T3SS effector proteins, is the main trigger of
macrophage cell death. Interestingly, although the total number
of dying alveolar macrophages was comparable in WT, DSTY and
DSTY/DPopB infected mice, there were significant qualitative
differences. In the absence of T3SS effector proteins, a significantly
larger fraction of the cells showed necrotic rather than apoptotic
features In addition, necrosis-like alveolar macrophage cell death
was also associated with caspase-1 mediated maturation and
secretion of the pro-inflammatory cytokine IL-1b, which is
generally described as pyroptosis [38]. These findings are
consistent with our previous in vitro observation of infection of
cultured macrophages with ExoS deficient bacteria switching the
mode of cell death from apoptosis to necrosis [16]. However, the
polarization towards necrosis was again lost upon additional
deletion of PopB. The above described differences in cell death
and IL-1b production were confirmed in vitro in a murine
macrophage cell line, suggesting that the in vivo differences reflect
a direct effect of the bacteria on macrophages. Together, these
data indicate that P. aeruginosa can trigger apoptosis independently
of the formation of a T3SS translocation pore and the injection of
T3SS effector proteins. In addition, PopB-mediated formation of
a T3SS translocation pore, without injection of the T3SS effector
proteins ExoS, ExoT or ExoY, induces pro-inflammatory necrosis.
However, as soon as T3SS effector proteins are injected, necrosis is
rapidly switched to non-inflammatory apoptosis, most likely as
a result of ExoS-mediated inhibition of caspase-1. The T3SS-
independent apoptosis observed upon infection with DSTY/
DPopB bacteria might be triggered by other toxins that are
secreted by P. aeruginosa, such as pyocyanin, which induces
apoptosis of neutrophils [39,40]. Necrosis initiated by DSTY
bacteria excludes a role for any of the four known T3SS effector
proteins. Despite extensive characterization of the P. aeruginosa
T3SS in several laboratories, no other T3SS effector proteins have
been identified. Cell membrane permeabilization by the trans-
location pore has also been suggested to trigger ion fluxes or other
events [8,41–43], some of which might signal necrosis. Alterna-
tively, we cannot exclude the possibility that PopB has a direct
effect that is independent from the formation of the pore. In this
Figure 3. Inflammatory cell infiltration and cell death in lungs
of mice infected with different P. aeruginosa T3SS mutants.
C57BL/6 mice were infected intratracheally with 1.16 cfu of P.
aeruginosa DSTY or DSTY/DPopB strain for 4.5 h. The cells were
analyzed by flow cytometry as described in materials and methods. A.
The number of macrophages and PMNs in BALF was counted. B. Total
numbers of dead macrophages and PMNs were calculated as the sum
of check Annexin-Vpos Sytoxneg, Annexin-Vneg Sytoxpos, and Annexin-
Vpos Sytoxpos cells. C. The mode of macrophage death was determined
by separating Annexin-Vpos Sytoxneg from Annexin-Vneg Sytoxpos cells
(n = 6 mice per group; NI were used as a control). The data are
expressed as means (+/2 SD) and are representative of 3 independent
experiments.
doi:10.1371/journal.pone.0041547.g003
Figure 4. IL-1b maturation and secretion in lungs of mice
infected with different P. aeruginosa T3SS mutants. C57BL/6 mice
were infected intratracheally with 1.16 cfu of WT P. aeruginosa or DSTY
or DSTY/DPopB mutants, and after 4.5 h, BALF was isolated and
analyzed by SDS-PAGE and western blotting for the presence of mature
IL-1b. The corresponding total lung extracts were also analyzed by
western blotting for the presence of pro IL-1b. Results are represen-
tative of six different mice per experimental condition.
doi:10.1371/journal.pone.0041547.g004
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context, IL-8 production induced by Yersinia pseudotuberculosis has
been shown to require YopB, a functional homolog of PopB, while
pore formation is not required [44]. Furthermore, binding of
caspase-1 with the PopB homologs SipB and IpaB has been
suggested to contribute to caspase-1 activation in response to
Salmonella and Shigella infection [45,46], respectively. However, by
co-immunoprecipitation we were unable to demonstrate binding
between caspase-1 and PopB (data not shown). Recently, T3SS
rod and needle proteins were found to be sensed in the host cell
cytoplasm by specific members of the NAIP protein family, which
then triggers activation of the NLRC4 inflammasome that is
responsible for caspase-1 mediated proIL-1b maturation and
pyroptotic cell death [24–26]. It is therefore tempting to speculate
that also the T3SS translocator protein PopB is similarly sensed by
a specific NAIP protein, leading to inflammasome activation.
Resistance to antibiotics is a major problem in the treatment of
P. aeruginosa infections in critically ill patients. It might be possible
to develop T3SS inhibitors as novel antibacterial therapeutics with
modes of action distinct from conventional antibiotics. Adminis-
tration of monoclonal antibodies against the T3SS needle-tip
protein PcrV has previously demonstrated efficacy against
laboratory strains of P. aeruginosa in a murine model [47], and
recently it entered Phase I/II clinical trials [48]. Efforts have been
directed at developing inhibitors that block other aspects of the
P. aeruginosa T3SS. For example, small molecule inhibitors of
ExoU’s phospholipase activity and ExoS’s ADPRT activity have
been identified, and each one could protect against killing of the
host in models of P. aeruginosa infection [18,49]. Our results show
that targeting the T3SS effector proteins might not be the best
approach and indicate that interfering with the formation or
activity of the T3SS translocation pore might be a better
approach. Recently, screening of a compound library resulted in
the discovery of five compounds that inhibit the activity of the
P. aeruginosa T3SS apparatus and the secretion of all its effector
proteins [50]. The molecular targets of these inhibitors are not
known, but the observed spectrum of activity against T3SS in
three bacterial species points to a conserved target, possibly PopB.
Methods
Ethics Statement
All experiments were approved by and performed in accor-
dance with the guidelines of the animal ethical committee of
Ghent University (permit number LA1400091, approval ID 04/
12). All efforts were made to ameliorate suffering of animals. Mice
were anesthetized by intraperitoneal injection of a mixture of
ketamine (100 mg/kg) and xylazine (10 mg/kg).
Bacterial Strains
The P. aeruginosa laboratory strain PAK (which has the effector
toxins ExoS, ExoT, ExoY but lacks the ExoU gene) and mutants
thereof with specific chromosomal deletions DExoS/DExoT/DExoY
or DExoS/DExoT/DExoY/DPopB have been described [51,52].
Bacterial cultures were grown in Luria–Bertani broth (LB) at
37uC.
In vitro Infection of MF4/4 Cells
The immortalized murine macrophage cell line MF4/4 [53]
was cultured at 37uC with 5% CO2 in RPMI 1640 supplemented
with 10% fetal bovine serum, 2 mM L-glutamine, 100 U/ml
penicillin, 100 mg/ml streptomycin sulfate, 1 mM sodium pyru-
vate and 261025 M b-mercaptoethanol. Cells were seeded at
106 cell per well in six-well plates and 4 h before infection they
were stimulated with 100 ng/ml LPS. Cells were infected with
Figure 5. Cell death and IL-1b maturation upon infection of the
MF4/4 macrophage cell line with different P. aeruginosa T3SS
mutants. MF4/4 cells were pre-stimulated with 100 ng/ml LPS for 4 h
and infected with WT P. aeruginosa or DSTY or DSTY/DPopB mutant
strains at a MOI of 100. Non infected cells prestimulated with 100 ng/ml
LPS for 4 h were used as a control. A. LDH release in the culture
medium was determined by spectrophotometry as described in
materials and methods and is expressed as optical density (absorbance)
at 490 nm. Results are the mean +/2 SD of triplicates and are
representative for four independent experiments. B. Caspase-3 activity
in cell extracts was measured in a fluorometric assay with Ac-DEVD-
AMC and is expressed as change in fluorescence over time (Df/min).
Results are the mean +/2 SD of triplicates and are representative of
three independent experiments. C. Culture supernatants (SN) were
collected and analyzed for the presence of mature IL-1b by
immunoprecipitation of IL-1b followed by SDS-PAGE and western
blotting. The corresponding total cell lysates were analyzed for the
presence of proIL-1b by western blotting. Results are representative of
three independent experiments.
doi:10.1371/journal.pone.0041547.g005
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P. aeruginosa at a multiplicity of infection of 100. Before lysing cells
and collecting supernatants, bacteria were killed by adding
100 mg/ml gentamicin and 50 mg/ml chloramphenicol. Cells
were lysed in 250 ml lysis buffer (50 mM Hepes pH 7.6, 200 mM
NaCl, 0.1% NP40, and 5 mM ethylenediaminetetraacetic acid
[EDTA]).
Mouse Model of Acute Pneumonia
Eight-week-old female C57BL/6 mice (BioServices Janvier,
Schuijk, The Netherlands) that were kept under ‘Specific Pathogen
Free’ conditions were intratracheally instillated with P. aeruginosa as
described [54]. Bacterial cultures were grown overnight in LB
medium at 37uC, diluted 1/100, and grown to exponential phase.
Bacteria were collected by centrifugation and re-suspended to the
appropriate density of colony forming units (cfu)/ml in phosphate
buffer saline (PBS), as determined by optical density measurement
and plating of serial dilutions on Nutrient Broth agar plates. Mice
were anesthetized by intraperitoneal injection of a mixture of
ketamine (100 mg/kg) and xylazine (10 mg/kg). Bacterial solu-
tions were administered by intratracheal instillation of 1616 cfu
(for measurement of bacterial clearance) or 86107 cfu (for survival
assays) in 50 ml of PBS. Survival rate was followed for 48 hours
after infection. Bacterial clearance was measured by determining
the number of bacteria in lung homogenates at different times post
infection. Lung homogenates were diluted serially and cultured on
agar plates for 24 h at 37uC for assessment of the bacterial load.
Bronchoalveolar Lavage and Preparation of Lung Extracts
After the indicated times of infection the trachea was exposed
through a midline incision and a sterile catheter was inserted.
Bronchoalveolar lavage was performed by instilling two aliquots of
0.5 ml PBS. BALF was retrieved, centrifuged and filtered (syringe
0.22-mm filter, Millipore, Bedford, USA). The lungs were
homogenized in 1 ml PBS and Laemmli loading buffer was added
for western blot analysis.
IL-1b Immunoprecipitation
IL-1b was immunoprecipitated from the cell supernatant by the
addition of 10% lysis buffer (50 mM Hepes pH 7.6, 200 mM
NaCl, 0.1% NP40, and 5 mM ethylenediaminetetraacetic acid
[EDTA]) and incubation for 15 h with 2 mg of a rat monoclonal
anti-IL-1b antibody (MAB401, R&D systems), followed by
incubation with protein G-sepharose (Amersham Biosciences) for
3 h. The beads were washed four times with lysis buffer before
elution with Laemmli buffer.
Western Blotting
Total cell extracts, BALF and IL-1b immunoprecipitations were
separated by SDS-PAGE and analyzed by western blotting and
immunodetection with anti-IL-1b antibodies (AF-401-NA, R&D
systems). Total cell extracts and IL-1b immunoprecipitates were
separated by SDS-PAGE and analyzed by western blotting and
immunodetection with anti-IL-1b antibodies (AF-401-NA, R&D
systems) and HRP-linked anti-mouse Ig (Amersham Biosciences).
Immunoreactivity was revealed with the enhanced chemilumines-
cence method (NENTM Renaissance, NEN Life Sciences
Products).
Analysis of Caspase-3 Activity and Lactate
Dehydrogenase Release
Caspase-3-like activity was measured by incubating cell extracts
with Ac-DEVD-AMC and monitoring the release of 7-amino-4-
methyl coumarin (AMC) in a fluorometer as described pre-
viously [55].
Lactate dehydrogenase (LDH) release in the culture super-
natants of cells at the indicated time points after infection was
quantified by using a cytotoxicity assay kit (Cytotox 96; Promega,
Charbonnieres, France).
Flow Cytometric Analysis of Bronchoalveolar (BAL)
Immune Cell Subsets and Cell Death Type
BAL macrophage/dendritic cell (MF/DC) and neutrophil
(PMN) populations and the mode of cell death were analyzed by
flow cytometry on a triple-laser (405 nm, 488 nm, 635 nm) LSR-
II with FACSDiva software (BD Biosciences, San Jose, CA, USA).
After the indicated times of infection, BALF was retrieved and
concentrated by centrifugation. Cells were kept on ice and labeled
with anti-CD16/CD32 to block Fc receptor binding, PE-
conjugated anti-Gr1 and PerCP-Cy5.5-conjugated anti-CD11c
(all BD Pharmingen) at 4uC in the dark. After washing, cells were
dissolved in Annexin-V binding buffer with 0.02% MgCl2, 0.03%
CaCl2, 0.9% NaCl, 0.037% KCl, 0.024% sodium azide and
0.38% NaOH-Hepes. Alexa Fluor 488-conjugated Annexin-V
(5 ml) and the cell-impermeant Sytox Red Dead Cell stain (5 nM)
(both Invitrogen) were then added. MF/DC were identified as
cells that were CD11cpos, PMN as CD11cneg Gr1hi. Viable cells
were identified as Annexin-Vneg Sytoxneg, early apoptotic as
Annexin-Vpos Sytoxneg, early necrotic as Annexin-Vneg Sytoxpos,
and late apoptotic/necrotic as Annexin-Vpos Sytoxpos.
Experimental Groups and Statistical Analysis
Animals were randomly assigned to the experimental groups,
with a minimum of six animals per group. Differences in bacterial
loads between DSTY and DSTY/DPopB infected mice were
analyzed by the Mann-Whitney test where appropriate P values
,0.05 were regarded as statistically significant. Cell death and cell
death mode, measured on FACS, was analyzed with the Kruskall
wallis test where appropriate P values of ,0.05 were regarded as
statistically significant. Survival curves (Kaplan-Meyer plots) were
compared using a log-rank test. Final mortality counts were
compared with a Chi square test. Means and standard deviation
(SD) were compared with a student t test with 95% confidence
intervals. *, **, and *** represent 0.01#P#0.05, 0.001#P#0.01,
and P#0.001, respectively.
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